Targeting inducible nitric oxide in a first-in-class phase 1/2 trial in triple-negative breast cancer patients diminishes M2 macrophage polarization and led to a robust clinical response.

被引:0
|
作者
Chung, Andrew W. [1 ]
Anand, Kartik [2 ]
Niravath, Polly [3 ]
Gupta, Nakul [3 ]
Venta, Luz A. [3 ]
Schwartz, Mary R. [3 ]
Qian, Wei [3 ]
Xu, Yitian [3 ]
Zhang, Licheng [3 ]
Chen, Qiuying [4 ]
Attarwala, Nabeel [4 ]
Kuhn, John [5 ]
Patel, Tejal A. [6 ]
Rodriguez, Angel [7 ]
Belcheva, Anna [3 ]
Darcourt, Jorge [3 ]
Ensor, Joe E. [3 ]
Bernicker, Eric [3 ]
Pan, Ping-Ying [3 ]
Kaklamani, Virginia [5 ]
Chen, Shu-Hsia [3 ]
Chang, Jenny C. [3 ]
机构
[1] Texas A&M Univ, Houston, TX USA
[2] Great Plains Hlth, North Platte, NE USA
[3] Houston Methodist Canc Ctr, Houston, TX USA
[4] Weill Cornell Med, New York, NY USA
[5] Univ Texas, Hlth Sci Ctr San Antonio, San Antonio, TX USA
[6] MD Anderson Canc Ctr, Houston, TX USA
[7] Austin Canc Ctr, Austin, TX USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CT175
引用
收藏
页数:2
相关论文
共 42 条
  • [1] Phase 1B/2 clinical trial targeting nitric oxide in the treatment of chemo-refractory metaplastic triple-negative breast cancer patients
    Puri, Akshjot
    Ordonez, Adriana
    Anselme, Ann C.
    Guzman, Liliana
    Niravath, Polly
    Chang, Jenny C.
    CANCER RESEARCH, 2022, 82 (04)
  • [2] TRIM21-mediated Sohlh2 ubiquitination suppresses M2 macrophage polarization and progression of triple-negative breast cancer
    Ruihong Zhang
    Ying Shen
    Qi Zhang
    Xiaoning Feng
    Xuyue Liu
    Xiaoning Huo
    Jinhao Sun
    Jing Hao
    Cell Death & Disease, 14
  • [3] TRIM21-mediated Sohlh2 ubiquitination suppresses M2 macrophage polarization and progression of triple-negative breast cancer
    Zhang, Ruihong
    Shen, Ying
    Zhang, Qi
    Feng, Xiaoning
    Liu, Xuyue
    Huo, Xiaoning
    Sun, Jinhao
    Hao, Jing
    CELL DEATH & DISEASE, 2023, 14 (12)
  • [4] Triple-negative breast cancer influences a mixed M1/M2 macrophage phenotype associated with tumor aggressiveness
    Pe, Kristine Cate S.
    Saetung, Rattana
    Yodsurang, Varalee
    Chaotham, Chatchai
    Suppipat, Koramit
    Chanvorachote, Pithi
    Tawinwung, Supannikar
    PLOS ONE, 2022, 17 (08):
  • [5] A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer
    Chung, Andrew W.
    Anand, Kartik
    Anselme, Ann C.
    Chan, Alfred A.
    Gupta, Nakul
    Venta, Luz A.
    Schwartz, Mary R.
    Qian, Wei
    Xu, Yitian
    Zhang, Licheng
    Kuhn, John
    Patel, Tejal
    Rodriguez, Angel A.
    Belcheva, Anna
    Darcourt, Jorge
    Ensor, Joe
    Bernicker, Eric
    Pan, Ping-Ying
    Chen, Shu Hsia
    Lee, Delphine J.
    Niravath, Polly A.
    Chang, Jenny C.
    SCIENCE TRANSLATIONAL MEDICINE, 2021, 13 (624)
  • [6] SPP1 mRNA Expression Is Associated with M2 Macrophage Infiltration and Poor Prognosis in Triple-Negative Breast Cancer
    Chen, Yu-Chia
    Chen, Chia-Ching
    Chen, Rong-Fu
    Chen, Hsin-Hung
    Chen, Po-Ming
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (12) : 13499 - 13513
  • [7] OTUD5-mediated deubiquitination of YAP in macrophage promotes M2 phenotype polarization and favors triple-negative breast cancer progression
    Zhang, Yujiao
    Fan, Yizeng
    Jing, Xin
    Zhao, Lin
    Liu, Tianjie
    Wang, Lu
    Zhang, Lifen
    Gu, Shanzhi
    Zhao, Xinhan
    Teng, Yan
    CANCER LETTERS, 2021, 504 : 104 - 115
  • [8] SPI1-mediated transcriptional activation of CEP55 promotes the malignant growth of triple-negative breast cancer and M2 macrophage polarization
    Liu, Yuanwei
    Dong, Ming
    Jia, Yong
    Yang, Dezhen
    Hui, Yang
    Yang, Xiaodong
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 262
  • [9] Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNBC) progression and M2 macrophage functions under the oncogenic stress
    Al Haq, Aushia Tanzih
    Tseng, Hong-Yu
    Chen, Li-Mei
    Wang, Chien-Chia
    Hsu, Hsin-Ling
    CELL DEATH & DISEASE, 2022, 13 (01)
  • [10] Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNBC) progression and M2 macrophage functions under the oncogenic stress
    Aushia Tanzih Al Haq
    Hong-Yu Tseng
    Li-Mei Chen
    Chien-Chia Wang
    Hsin-Ling Hsu
    Cell Death & Disease, 13